Sarcoma
Whole-genome methylation shows promise as multicancer early-detection test
Evaluation of multiple classifiers, both alone and in combination, supports the decision to focus on cell-free DNA methylation patterns to detect cancer and predict the cancer signal origin, according to a presentation at ESMO Congress 2021.
ASTRO issues guideline on use of radiation therapy for adults with soft tissue sarcoma
American Society for Radiation Oncology issued its first clinical guideline for sarcoma.
Survival rates among AYAs with certain cancers show little to no improvement
Although 5-year survival rates have increased for multiple cancer types among adolescents and young adults, little or no improvement has been observed for some common malignancies in this population, according to findings published in Cancer.
Molecular tumor profiling beneficial in pediatric solid cancers
Molecular profiling of solid tumors in children and young adults has a significant impact on diagnosis and treatment recommendations, according to results of an interim analysis presented during the virtual ASCO Annual Meeting.
Gene-edited T-cell therapy shows ‘promising efficacy’ for rare sarcomas
Nearly 40% of patients with advanced or metastatic synovial sarcoma or myxoid/round cell liposarcoma responded to therapy with afamitresgene autoleucel, according to results of a phase 2 study.
Going the extra mile — or 26.2, to be exact — to fulfill a promise to a patient
Three weeks after Christmas, James H. Flint, MD, set an alarm a bit earlier than normal for a Sunday.
Pelvic ring reconstruction had high union rate after iliosacral resection of Ewing sarcoma
Society of Surgical Oncology announces president, executive council officers
Society of Surgical Oncology announced its newly elected executive council officers for the 2021-2022 term.
NCCN Foundation presents awards to young investigators
FDA grants fast track designation to annamycin for sarcoma lung metastases
The FDA granted fast track designation to annamycin for the treatment of patients with lung metastases from soft tissue sarcoma, according to a press release from the agent’s manufacturer.